UBS Principal sells 5.44 percent stake in Fortis Healthcare for Rs 443 crore

Published On 2018-05-04 05:00 GMT   |   Update On 2018-05-04 05:00 GMT

New Delhi: UBS Principal Capital Asia offloaded 5.44 percent stake in Fortis Healthcare for over Rs 443 crore through an open market transaction.


According to bulk deal data available with the National Stock Exchange (NSE), UBS shed a total of 2,82,31,975 shares, amounting to 5.44 per cent stake, of Fortis.



The shares were sold on Rs 157 apiece, valuing the transaction at Rs 443.24 crore, the data showed.

Meanwhile, York Asian Opportunities Investments Master Fund, York Asian Strategic Meteric Master, York Multi-Strategy Master Fund together picked up 2,82,35,492 shares of Fortis.


Shares of Fortis closed at Rs 157.95 apiece on the NSE, down 0.6 percent from the previous close.


Last week, Fortis had announced that its board will meet on May 10 to take a decision on the binding bids for the company as recommended by the expert advisory committee.


The company has received binding offers from four entities - KKR-backed Radiant Life Care, Malaysian major IHH Healthcare, Manipal/TPG consortium and Munjal and Burman family offices.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News